Celldex Therapeutics, Inc.
(CLDX - NASDAQ)
33,66 USD
📋 Profilo Aziendale

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases.

|